The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25053021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Irene Reyes-Resina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation, Spanish MCIN/AEI/10.13039/550 501100011033.
Abstract (Originalsprache)
One of the hallmarks of Parkinson’s disease (PD) is the alteration in the expression and function of NMDA receptor (NMDAR) and cannabinoid receptor 1 (CB1R). The presence of CB1R-NMDAR complexes has been described in neuronal primary cultures. The activation of CB1R in CB1R-NMDAR complexes was suggested to counteract the detrimental NMDAR overactivation in an AD mice model. Thus, we aimed to explore the role of this receptor complex in PD. By using Bioluminescence Resonance Energy Transfer (BRET) assay, it was demonstrated that α-synuclein induces a reorganization of the CB1R-NMDAR complex in transfected HEK-293T cells. Moreover, α-synuclein treatment induced a decrease in the cAMP and MAP kinase (MAPK) signaling of both CB1R and NMDAR not only in transfected cells but also in neuronal primary cultures. Finally, the interaction between CB1R and NMDAR was studied by Proximity Ligation Assay (PLA) in neuronal primary cultures, where it was observed that the expression of CB1R-NMDAR complexes was decreased upon α-synuclein treatment. These results point to a role of CB1R-NMDAR complexes as a new therapeutic target in Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, 08028 Barcelona, Spain.
- Network Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
- Institut de Neurociències UB, Campus Mundet, Passeig de la Vall d'Hebron 171, 08035 Barcelona, Spain.
- Molecular Neurobiology Laboratory, Department Biochemistry and Molecular Biomedicine, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
ORCID-Profile: Irene Reyes-Resina, Gemma Navarro
Förderung
- Spanish Ministry of Science and Innovation
- Spanish MCIN/AEI/10.13039/550 501100011033
Zitieren
APA
Reyes-Resina, I., Lillo, J., Raïch, I., Rebassa, J. B., & Navarro, G. (2024). The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053021
Vancouver
Reyes-Resina I, Lillo J, Raïch I, Rebassa JB, Navarro G. The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053021
BibTeX
@article{ReyesResina2024,
author = {Reyes-Resina, Irene and Lillo, Jaume and Raïch, Iu and Rebassa, Joan Biel and Navarro, Gemma},
title = {The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25053021}
}
EUVIMED